Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04150250 · ClinicalTrials.gov registry record · Phase 2
Cholera Anti-Secretory Treatment Trial
A Phase 2 study, sponsored by PATH.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
NCT04150250 is a Phase 2 study that has completed, run by PATH. The registered enrollment target is 47 participants.
The verdict
NCT04150250, a Phase 2 study, has completed, sponsored by PATH.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
Study Summary
This trial was designed to assess safety and preliminary efficacy of oral doses of iOWH032 on diarrhea output and clinical symptoms after a cholera challenge in healthy adult participants.
Interventions
- DRUG Placebo
- DRUG Antibiotics
- DRUG iOWH032
- OTHER V. cholerae Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-07-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04150250
The ClinicalTrials.gov registry entry for NCT04150250 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PATH, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04150250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04150250 about?
NCT04150250 is a clinical study titled "Cholera Anti-Secretory Treatment Trial". This trial was designed to assess safety and preliminary efficacy of oral doses of iOWH032 on diarrhea output and clinical symptoms after a cholera challenge in healthy adult participants.
What is the current status of trial NCT04150250?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2019-11-04. Estimated completion is 2020-07-27.
What interventions are being tested in trial NCT04150250?
The interventions under investigation include: Placebo (DRUG), Antibiotics (DRUG), iOWH032 (DRUG), V. cholerae Challenge (OTHER).
Who is sponsoring clinical trial NCT04150250?
This trial is sponsored by PATH, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.